Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test. (IDAHeT)
Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test in Patients At Extremely High Risk of Postoperative Venous Thromboembolism.
Sponsor: Pirogov Russian National Research Medical University
Terminated
Lack of the eligible patients
Other terminated trials from Pirogov Russian National Research Medical University
See all terminations from Pirogov Russian National Research Medical University
Other Venous Thromboembolism trials with similar outcome
This PHASE4 trial investigates Venous Thromboembolism and is currently terminated or withdrawn. Pirogov Russian National Research Medical University leads this study, which shows 9 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Feb 2025 — Sep 2025 [monthly]
Terminated PHASE4
Status: Unknown → Terminated
-
Sep 2024 — Feb 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Mar 2024 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Mar 2022 — Mar 2024 [monthly]
Recruiting PHASE4
-
Oct 2021 — Mar 2022 [monthly]
Recruiting PHASE4
-
Apr 2021 — Oct 2021 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — Apr 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Pirogov Russian National Research Medical University
For direct contact, visit the study record on ClinicalTrials.gov .